716 NL-201 induces inflammation in a 'cold' tumor microenvironment through upregulation of MHC-I, expansion of the TCR repertoire, and potent antitumor activity when combined with PD-1 inhibition

Ryan Swanson, Carl Walkey, Christie Mortales, Benjamin Dutzar, Jerry Chen, Alex Chen, Justin Huard, Luis Blancas-Mejia

Open source

DOI
10.1136/jitc-2021-sitc2021.716
Published
November
Container
Journal for ImmunoTherapy of Cancer
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2021-sitc2021.716,
  title = {716 NL-201 induces inflammation in a 'cold' tumor microenvironment through upregulation of MHC-I, expansion of the TCR repertoire, and potent antitumor activity when combined with PD-1 inhibition},
  author = {Ryan Swanson and Carl Walkey and Christie Mortales and Benjamin Dutzar and Jerry Chen and Alex Chen and Justin Huard and Luis Blancas-Mejia},
  year = {2021},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1136/jitc-2021-sitc2021.716},
  url = {https://doi.org/10.1136/jitc-2021-sitc2021.716}
}

RIS

TY  - JOUR
TI  - 716 NL-201 induces inflammation in a 'cold' tumor microenvironment through upregulation of MHC-I, expansion of the TCR repertoire, and potent antitumor activity when combined with PD-1 inhibition
AU  - Ryan Swanson
AU  - Carl Walkey
AU  - Christie Mortales
AU  - Benjamin Dutzar
AU  - Jerry Chen
AU  - Alex Chen
AU  - Justin Huard
AU  - Luis Blancas-Mejia
PY  - 2021
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2021-sitc2021.716
UR  - https://doi.org/10.1136/jitc-2021-sitc2021.716
ER  - 

APA

Swanson, R., Walkey, C., Mortales, C., Dutzar, B., Chen, J., Chen, A., Huard, J., & Blancas-Mejia, L. (2021). 716 NL-201 induces inflammation in a 'cold' tumor microenvironment through upregulation of MHC-I, expansion of the TCR repertoire, and potent antitumor activity when combined with PD-1 inhibition. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2021-sitc2021.716

Source records